These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2292205)

  • 1. Chemotherapeutic activity of L-histidinol against spontaneous, autochthonous murine breast tumors.
    Stolfi RL; Martin DS
    Chemotherapy; 1990; 36(6):435-40. PubMed ID: 2292205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumors.
    Stolfi RL; Sawyer RC; Martin DS
    Cancer Res; 1987 Jan; 47(1):16-20. PubMed ID: 3791203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of L-histidinol and homoharringtonine on 5-fluorouracil and bis-chloroethylnitrosourea activity in a murine model.
    Warrington RC; Fang WD
    Anticancer Res; 1991; 11(5):1879-83. PubMed ID: 1768059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity, schedule, and proliferation dependence of infused L-histidinol after 5-fluorouracil in mice.
    Edelstein MB; Heilbrun LK
    Cancer Res; 1988 Mar; 48(6):1470-5. PubMed ID: 3345520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice.
    Zaharko D; Plowman J; Waud W; Dykes D; Malspeis L
    Cancer Res; 1992 Jul; 52(13):3604-9. PubMed ID: 1617631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice.
    Warrington RC; Cheng I; Fang WD
    J Natl Cancer Inst; 1987 Jun; 78(6):1177-83. PubMed ID: 3108563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists.
    Brandes LJ; LaBella FS; Warrington RC
    J Natl Cancer Inst; 1991 Sep; 83(18):1329-36. PubMed ID: 1886159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-histidinol in experimental cancer chemotherapy: improving the selectivity and efficacy of anticancer drugs, eliminating metastatic disease and reversing the multidrug-resistant phenotype.
    Warrington RC
    Biochem Cell Biol; 1992 May; 70(5):365-75. PubMed ID: 1353969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
    Warrington RC; Fang WD
    J Natl Cancer Inst; 1985 May; 74(5):1071-7. PubMed ID: 3858576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection by testosterone from fluorouracil-induced toxicity without loss of anticancer acitvity against autochthonous murine breast tumors.
    Stolfi RL; Sawyer RC; Nayak R; Spiegelman S; Martin DS
    Cancer Res; 1980 Aug; 40(8 Pt 1):2730-5. PubMed ID: 7388822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-fluorouracil-containing drug combination.
    Stolfi RL; Colofiore JR; Nord LD; Koutcher JA; Martin DS
    Cancer Res; 1992 Aug; 52(15):4074-81. PubMed ID: 1379119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of human colon carcinoma cells to anticancer drugs is enhanced by L-histidinol.
    Warrington RC; Cheng I; Fang WD
    Anticancer Res; 1994; 14(2A):367-72. PubMed ID: 8017835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-histidinol protection against cytotoxic action of cytosine arabinoside and 5-fluorouracil in cultured mouse spleen cells.
    Warrington RC; Fang WD
    J Natl Cancer Inst; 1982 Feb; 68(2):279-86. PubMed ID: 6950159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of potentiation of antitumor activity of 5-fluorouracil against adenocarcinoma 755 by L-cysteine.
    Iigo M; Hoshi A
    Biochem Pharmacol; 1986 Mar; 35(5):727-30. PubMed ID: 3954782
    [No Abstract]   [Full Text] [Related]  

  • 16. Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
    Warrington RC; Muzyka TG; Fang WD
    Cancer Res; 1984 Jul; 44(7):2929-35. PubMed ID: 6722819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic evaluation using clinical criteria in spontaneous, autochthonous murine breast tumors.
    Stolfi RL; Stolfi LM; Sawyer RC; Martin DS
    J Natl Cancer Inst; 1988 Mar; 80(1):52-5. PubMed ID: 3339639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity.
    Al Safarjalani ON; Rais R; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1449-55. PubMed ID: 22373605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-histidinol on the proliferation and anticancer drug susceptibility of cultured B16f10 melanoma cells.
    Warrington RC; Cheng I; Fang W
    Anticancer Res; 1991; 11(5):1863-7. PubMed ID: 1768057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach for improving the efficacy of experimental cancer chemotherapy using combinations of anticancer drugs and L-histidinol.
    Warrington RC
    Anticancer Res; 1986; 6(3 Pt B):451-64. PubMed ID: 3090929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.